|

 |
 |
 |
 |
|
 |
 |

|
2002
|
 |
 |
 |
2001
|

|

|
 |
% Change
|
 |
 |
 |
|
|
 |
 |
|
 |
|
|
|
 |
|
 |
 |
 |
Revenue
|
|
$
|
975,893
|
|
$
|
819,760
|
|
|
19.0
|
%
|
 |
Pro Forma Net Income
|
|
|
135,429
|
|
|
109,263
|
|
|
23.9
|
|
 |
Fully Diluted Pro Forma
Net Income Per Share 
|
|
|
0.32
|
|
|
0.25
|
|
|
28.0
|
|
 |
Research & Development Expense
|
|
|
120,875
|
|
|
89,247
|
|
|
35.4
|
|
 |
Total Assets
|
|
|
1,659,951
|
|
|
1,592,336
|
|
|
4.2
|
|
 |
Cash Flow from Operations
|
|
|
225,022
|
|
|
225,290
|
|
|
(0.1)
|
|
 |
Deferred Revenues
|
|
|
194,846
|
|
|
203,947
|
|
|
(4.5)
|
|
 |
 |
|
 |
|
 |
|
|
|
|
|
|
 |
|


 
|